Conceptio › recurrent-diffuse-large-b-cell-lymphoma
Topic
recurrent-diffuse-large-b-cell-lymphoma
2Documents about recurrent-diffuse-large-b-cell-lymphoma
Documents about recurrent-diffuse-large-b-cell-lymphoma
- Testing the Addition of an Immunotherapy Agent, Atezolizumab, When Given With the Usual Chemo-Immunotherapy Drug Combination (Rituximab Plus Gemcitabine and Oxaliplatin) for Relapsed/Refractory (That Has Come Back or Not Responded to Treatment) Transformed Diffuse Large B-Cell Lymphoma#325290ClinicalTrials.gov
- Nivolumab for Relapsed, Refractory, or Detectable Disease Post Chimeric Antigen Receptor T-cell Treatment in Patients With Hematologic Malignancies#329527ClinicalTrials.gov
Conceptio Knowledge Graph
Explore recurrent-diffuse-large-b-cell-lymphoma across the open knowledge archive
Explore cross-citations, verify licenses and provenance, and integrate recurrent-diffuse-large-b-cell-lymphoma research directly into AI agents via MCP or REST API.
Related topics
Topic record · derived from the Conceptio knowledge graph (shared subject terms across the corpus)
Retrieved via Conceptio: topic hubs link to canonical document pages with full provenance.
Retrieved via Conceptio: topic hubs link to canonical document pages with full provenance.